Novo Nordisk to Build $130M Diabetes Lab Facility

Nov 04, 2014

Genetic Engineering & Biotechnology News

Novo Nordisk says it is investing about $130 million in new laboratories at the firm's R&D campus in Måløv, Denmark. Construction is already underway for the new facility, called Diabetes Research House, and it should be complete in early 2016.

According to the company, with floor space of 16,500 square meters distributed on three stories, Diabetes Research House will have two laboratory wings, a middle building with office space, and an auditorium seating 450 people. Mads Krogsgaard Thomsen, Ph.D., Novo Nordisk's evp and CSO, said in a statement that the facility will provide an environment for diabetes research within biotechnology and protein chemistry.

"Here [at the facility] our researchers will be working closely together with leading scientists in Denmark and abroad on the discovery and development of new medicines for the treatment of type 1 and type 2 diabetes," said Thomsen. Read the full release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments